Boots year-end results
This article was originally published in The Rose Sheet
Executive Summary
Clearasil year-end sales increased 14.4% to $144.2 mil. (£1=$1.66), UK firm reports in preliminary year-end results issued June 5. Boots Healthcare International sales jumped 12.3% to $764.1 mil. at comparable exchange rates in fiscal year ended March 31. Profit before interest for the division was up 24.1% to $116.3 mil., Boots states. Company has exited non-core businesses and is focusing on BHI and Boots the Chemists...